179 related articles for article (PubMed ID: 12965264)
1. Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression.
Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM
J Neuroimmunol; 2003 Aug; 141(1-2):132-40. PubMed ID: 12965264
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing--remitting multiple sclerosis patients.
Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM
Mult Scler; 2005 Jun; 11(3):251-60. PubMed ID: 15957503
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity.
Hellings N; Gelin G; Medaer R; Bruckers L; Palmers Y; Raus J; Stinissen P
J Neuroimmunol; 2002 May; 126(1-2):143-60. PubMed ID: 12020966
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis.
Hafler DA; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Fukaura H
Ann N Y Acad Sci; 1997 Dec; 835():120-31. PubMed ID: 9616767
[TBL] [Abstract][Full Text] [Related]
5. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.
Greer JM; Csurhes PA; Cameron KD; McCombe PA; Good MF; Pender MP
Brain; 1997 Aug; 120 ( Pt 8)():1447-60. PubMed ID: 9278634
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.
Moldovan IR; Cotleur AC; Zamor N; Butler RS; Pelfrey CM
J Neuroimmunol; 2008 Jan; 193(1-2):161-9. PubMed ID: 18022700
[TBL] [Abstract][Full Text] [Related]
7. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
[TBL] [Abstract][Full Text] [Related]
8. Short-term evolution of autoreactive T cell repertoire in multiple sclerosis.
Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L
J Neurosci Res; 2001 Nov; 66(3):517-24. PubMed ID: 11746371
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in cytokine responses to myelin peptides in multiple sclerosis.
Pelfrey CM; Cotleur AC; Lee JC; Rudick RA
J Neuroimmunol; 2002 Sep; 130(1-2):211-23. PubMed ID: 12225904
[TBL] [Abstract][Full Text] [Related]
10. Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta.
Link J; Söderström M; Kostulas V; Olsson T; Höjeberg B; Ljungdahl A; Link H
J Neuroimmunol; 1994 Jan; 49(1-2):9-18. PubMed ID: 7507500
[TBL] [Abstract][Full Text] [Related]
11. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
[TBL] [Abstract][Full Text] [Related]
12. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production.
Pelfrey CM; Rudick RA; Cotleur AC; Lee JC; Tary-Lehmann M; Lehmann PV
J Immunol; 2000 Aug; 165(3):1641-51. PubMed ID: 10903775
[TBL] [Abstract][Full Text] [Related]
13. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
15. Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.
Nielsen CH; Börnsen L; Sellebjerg F; Brimnes MK
PLoS One; 2016; 11(1):e0146971. PubMed ID: 26756931
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.
Wing AC; Hygino J; Ferreira TB; Kasahara TM; Barros PO; Sacramento PM; Andrade RM; Camargo S; Rueda F; Alves-Leon SV; Vasconcelos CC; Alvarenga R; Bento CA
Immunology; 2016 Feb; 147(2):212-20. PubMed ID: 26781085
[TBL] [Abstract][Full Text] [Related]
17. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
Windhagen A; Anderson DE; Carrizosa A; Balashov K; Weiner HL; Hafler DA
J Neuroimmunol; 1998 Nov; 91(1-2):1-9. PubMed ID: 9846813
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis.
Vojdani A; Vojdani E; Cooper E
J Intern Med; 2003 Oct; 254(4):363-74. PubMed ID: 12974875
[TBL] [Abstract][Full Text] [Related]
19. Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types.
Greer JM; Trifilieff E; Pender MP
Front Immunol; 2020; 11():1891. PubMed ID: 32973782
[TBL] [Abstract][Full Text] [Related]
20. [Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone].
Yagi Y; Takahashi M; Nakamura Y
Rinsho Shinkeigaku; 1997 Jul; 37(7):575-9. PubMed ID: 9396353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]